Patients as Partners Europe

Launch Rate Ends Friday, February 28th

#PatientsEU2025
9th Annual Patients as Partners Europe Demonstrates:

• Transitioning from patient centricity to integrated patient engagement
• Utilizing patient experience data to assess the advancement of medicine development
• Protocol complexity to reduce patient burden
• Mastering diversity in patient recruitment
• Identifying the highest impact activities to speed up medicine development
• Establishing true collaborations in patient partnerships

Why Now?

It is essential to understand how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity. The R&D community is figuring out how patient data is being used and is finding solutions to reduce protocol complexity for patient ease. The R&D industry is also grappling with an understanding of how patient involvement can help advance sustainable clinical development? It is important to demonstrate the value of patient engagement in clinical trials and to know what’s on the regulatory landscape.

Experts from Sanofi, Regeneron, Chiesi, Johnson & Johnson, GSK, Boehringer Ingelheim, Lundbeck, Pfizer, Novo Nordisk, AstraZeneca, Roche and more will gather with patient advocacy to address:

• The future of patient informed research
• Patient preferences and decentralized clinical trials
• Advancing health equity, diversifying and inclusivity in clinical trials
• The patient experience data landscape
• Turning patient insights into action
• Mapping and demonstrating value for patient engagement
• Patient burden-reducing solutions and technologies
• HTA/Regulatory requirements and patient engagement in drug development

2025 Co-Chairs

Co-Chair
Wafae Iraqi, PharmD, PhD, EMEA
Johnson and Johnson Innovative Medicine

Co-Chair
Alfred Samuels
Patient Advocate

Co-Chair
Victoria DiBiaso
Sanofi

2025 Keynotes and Featured Speakers

Keynote
Harry Verbunt,
Patient Advocate

Keynote
Temi Olonisakin, MD
Patient Advocate

Keynote
Peter DiBiaso,
Patient Advocate

Lea-Isabelle Proulx, PhD
Roche

Beyza Klein,
Johnson & Johnson Innovative Medicine

Catherine Coulouvrat, MD
Sanofi

Marisa Minetti,
Chiesi

Gisela Linthorst,
Azafaros

What to Expect

The 9th annual #PatientsEU2025 conference offers an unparalleled opportunity to hear from pharma R&D and patient advocacy together on how patient involvement gets done to drive greater efficiencies in clinical research with better outcomes. The conference prioritizes the patient voice for the R&D industry to learn how we can move into the next phase of patient centricity to better support access and decision-making for patients, increase diverse representation to connect with a wide range of patient communities, and how this transformation will make finding clinical research easier for patients and allow for faster and more efficient clinical development.

Patients First!

Thanks to patients, we have the following patient initiatives in place:

• Patient advisory groups to gain their input on the program agenda
• Patients have a wide choice of speaking opportunities
• Dedicated patient-led sessions, panels and roundtables
• Patients in clinical trials registration scholarship program covering 100% of the attendee registration fee